InvestorsHub Logo
Followers 229
Posts 21457
Boards Moderated 2
Alias Born 08/03/2006

Re: None

Thursday, 03/30/2023 8:41:45 AM

Thursday, March 30, 2023 8:41:45 AM

Post# of 853
GSK and SCYNEXIS Announce an Exclusive Agreement to Commercialise and Further Develop Brexafemme (ibrexafungerp), a Novel, First-in-Class Medicine to Treat Fungal Infection


https://finance.yahoo.com/news/gsk-scynexis-announce-exclusive-agreement-110500617.html


Booyah


Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?

"We hope not." Richard Dennis

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SCYX News